
Join to View Full Profile
1230 York AveNew York, NY 10065
Phone+1 212-327-7153
Fax+1 212-327-8232
Dr. Frew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of New South Wales Faculty of MedicineClass of 2009
Certifications & Licensure
- NY State Medical License 2019 - 2022
Clinical Trials
- Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab Start of enrollment: 2019 May 28
- Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab. Start of enrollment: 2020 Jun 01
- An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab Start of enrollment: 2020 Feb 03
Publications & Presentations
PubMed
- Malignancy risk differs between hidradenitis suppurativa and pilonidal sinus disease.Tara Sholji, Raaisa Islam, James Pham, Cindy Kok, John W Frew
Journal of the American Academy of Dermatology. 2025-06-01 - Evaluating the Quality and Readability of Online Information on Hidradenitis Suppurativa: A Systematic Review.Marra Aghajani, Ericka Maye, Kate Burrell, Cindy Kok, John W Frew
Clinical and Experimental Dermatology. 2025-05-28 - Comparison of Keratinocyte Cancer Tumour and Defect Sizes Treated by Mohs Micrographic Surgery: Sydney Versus Outside Metropolitan Sydney.Marjia Johns, Hannah Kunst, Vivian Tng, John Frew, Cindy Kok
The Australasian Journal of Dermatology. 2025-05-01
Press Mentions
- Is a Vaccine for Melanoma on the Cards?December 14th, 2022
- Aussie HS Patients Show Good Responses to JAK Inhibitor TherapyAugust 9th, 2022
- The Fallout When Dermatologists and Patients Don’t AgreeAugust 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: